Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, Ilenia Iaia, Chiara Donini, Annamaria Massa, Maria Laura Centomo, Marco Basiricò, Elisa Vigna, Alberto Pisacane, Franco Picciotto, Enrico Berrino, Caterina Marchiò, Alessandra Merlini, Luca Paruzzo, Stefano Poletto, Daniela Caravelli, Andrea Michela Biolato, Valentina Bortolot, Elisa Landoni, Marco Ventin, Cristina R. Ferrone, Massimo Aglietta, Gianpietro Dotti, Valeria Leuci, Fabrizio Carnevale-Schianca & Dario Sangiolo. (2023) CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Zhaozhao Chen, Yu Hu & Heng Mei. (2023) Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies. Advanced Science.
Crossref
Crossref
Krishna Mahanti & Sankar Bhattacharyya. (2023) Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting.. Translational Research.
Crossref
Crossref
Elisa Cappuzzello, Emilia Vigolo, Giulia D’Accardio, Giuseppe Astori, Antonio Rosato & Roberta Sommaggio. (2023) How can Cytokine-induced killer cells overcome CAR-T cell limits. Frontiers in Immunology 14.
Crossref
Crossref
Juan José Soto-Castillo, Lucía Llavata-Marti, Roser Fort-Culillas, Pablo Andreu-Cobo, Rafael Moreno, Carles Codony, Xavier García del Muro, Ramon Alemany, Josep M. Piulats & Juan Martin-Liberal. (2023) SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy. International Journal of Molecular Sciences 24:13, pages 11143.
Crossref
Crossref
Chunmei Hu, Min Liu, Yutao Li, Yi Zhao, Amit Sharma, Haotian Liu & Ingo G. H. Schmidt-Wolf. (2023) Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer. Frontiers in Immunology 14.
Crossref
Crossref
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Ahmed Mohsin Huran Al Jawadri, Hayder Abdullah Talib, Abdul Kareem J. Al-Azzawi, Rahman S. Zabibah & Ahmed Ali. (2023) Cancer Stem Cells in Colorectal Cancer: Implications for Targeted Immunotherapies. Journal of Gastrointestinal Cancer.
Crossref
Crossref
Víctor Albarrán, María Luisa Villamayor, Javier Pozas, Jesús Chamorro, Diana Isabel Rosero, María San Román, Patricia Guerrero, Patricia Pérez de Aguado, Juan Carlos Calvo, Coral García de Quevedo, Carlos González & María Ángeles Vaz. (2023) Current Landscape of Immunotherapy for Advanced Sarcoma. Cancers 15:8, pages 2287.
Crossref
Crossref
Bo Wu, Xiang Shi, Meixi Jiang & Hongxu Liu. (2023) Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. Molecular Cancer 22:1.
Crossref
Crossref
Hassan Dianat-Moghadam, Mohammadreza Sharifi, Rasoul Salehi, Mohsen Keshavarz, Mehdi Shahgolzari & Zohreh Amoozgar. (2023) Engaging stemness improves cancer immunotherapy. Cancer Letters 554, pages 216007.
Crossref
Crossref
Lu Wang, Xinyi Chen, Lu Zhang, Boning Niu, Long Li, Yinan Sun & Xianglin Yuan. (2022) CAR cell design strategies in solid tumors. International Immunopharmacology 113, pages 109345.
Crossref
Crossref
Cristina Chiriaco, Chiara Donini, Marco Cortese, Stefano Ughetto, Chiara Modica, Ilaria Martinelli, Alessia Proment, Letizia Vitali, Lara Fontani, Monica Casucci, Paolo Maria Comoglio, Silvia Giordano, Dario Sangiolo, Valeria Leuci & Elisa Vigna. (2022) Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Julie Lasvergnas, Marie Naigeon, Kader Chouahnia, Laurent Zelek, Nathalie Chaput & Boris Duchemann. (2022) Adoptive cell therapies in thoracic malignancies. Cancer Immunology, Immunotherapy 71:9, pages 2077-2098.
Crossref
Crossref
Tao Yu, Shao-kun Yu, Yan Xiang, Kai-Hua Lu & Ming Sun. (2022) Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. Frontiers in Immunology 13.
Crossref
Crossref
Cristiam Moreno Tellez, Yan Leyfman, Sandra P. D'Angelo, Breelyn A. Wilky & Armelle Dufresne. (2022) Immunotherapy in Sarcoma. Surgical Oncology Clinics of North America 31:3, pages 381-397.
Crossref
Crossref
Hassan Dianat-Moghadam, Amir Mahari, Reza Salahlou, Mostafa Khalili, Mehdi Azizi & Hadi Sadeghzadeh. (2022) Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Andreas Hombach, Markus Barden, Lisa Hannappel, Markus Chmielewski, Gunter Rappl, Agapios Sachinidis & Hinrich Abken. (2022) IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors. Molecular Therapy 30:2, pages 593-605.
Crossref
Crossref
Lindsay Jones Talbot, Ashley Chabot, Amy Funk, Phuong Nguyen, Jessica Wagner, Aaron Ross, Heather Tillman, Andrew Davidoff, Stephen Gottschalk & Christopher DeRenzo. (2021) A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells. Frontiers in Immunology 12.
Crossref
Crossref
Philipp Wendel, Lisa Marie Reindl, Tobias Bexte, Leander Künnemeyer, Vinzenz Särchen, Nawid Albinger, Andreas Mackensen, Eva Rettinger, Tobias Bopp & Evelyn Ullrich. (2021) Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy. Cancers 13:6, pages 1481.
Crossref
Crossref
Chiara Donini, Ramona Rotolo, Alessia Proment, Massimo Aglietta, Dario Sangiolo & Valeria Leuci. (2021) Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells 10:3, pages 543.
Crossref
Crossref
Harsimrat Kaur Birdi, Anna Jirovec, Serena Cortés-Kaplan, Joel Werier, Carolyn Nessim, Jean-Simon Diallo & Michele Ardolino. (2021) Immunotherapy for sarcomas: new frontiers and unveiled opportunities. Journal for ImmunoTherapy of Cancer 9:2, pages e001580.
Crossref
Crossref
Rafet Basar, May Daher & Katayoun Rezvani. (2020) Next-generation cell therapies: the emerging role of CAR-NK cells. Hematology 2020:1, pages 570-578.
Crossref
Crossref
Valeria Leuci, Chiara Donini, Giovanni Grignani, Ramona Rotolo, Giulia Mesiano, Erika Fiorino, Loretta Gammaitoni, Lorenzo D'Ambrosio, Alessandra Merlini, Elisa Landoni, Enzo Medico, Sonia Capellero, Lidia Giraudo, Giulia Cattaneo, Ilenia Iaia, Ymera Pignochino, Marco Basiricò, Elisa Vigna, Alberto Pisacane, Franca Fagioli, Soldano Ferrone, Massimo Aglietta, Gianpietro Dotti & Dario Sangiolo. (2020) CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes. Clinical Cancer Research 26:23, pages 6321-6334.
Crossref
Crossref
Ying Zhang & Ingo G. H. Schmidt‐Wolf. (2020) Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy. Journal of Cellular Physiology 235:12, pages 9291-9303.
Crossref
Crossref
Rafet Basar, May Daher & Katayoun Rezvani. (2020) Next-generation cell therapies: the emerging role of CAR-NK cells. Blood Advances 4:22, pages 5868-5876.
Crossref
Crossref
Manuel Gotti, Irene Defrancesco, Mario D’Angelo, Sabrina Basso, Luca Crotto, Alfredo Marinelli, Cristina Maccalli & Vincenzo Iaconianni. (2020) Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers. Frontiers in Immunology 11.
Crossref
Crossref
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, Reni Kitte, Sarah Dluczek, Alexander Strauß, André-René Blaudszun, Tetyana Yevsa, Stephan Fricke & Uta Kossatz-Boehlert. (2020) Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology 11.
Crossref
Crossref
Jie Ni, Belamy B. Cheung, Julia Beretov, Wei Duan, Joseph Bucci, David Malouf, Peter Graham & Yong Li. (2020) CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo. Experimental Cell Research 388:2, pages 111850.
Crossref
Crossref
Matthew J. Frank, Niclas Olsson, Andy Huang, Sai-Wen Tang, Robert S. Negrin, Joshua E. Elias & Everett H. Meyer. (2020) A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells. Cytotherapy 22:3, pages 135-143.
Crossref
Crossref
Kun-Lin Chen, Deng Li, Ting-Xuan Lu & Shu-Wei Chang. (2020) Structural Characterization of the CD44 Stem Region for Standard and Cancer-Associated Isoforms. International Journal of Molecular Sciences 21:1, pages 336.
Crossref
Crossref
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, Francis J. Hornicek & Zhenfeng Duan. (2020) Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications. Cancer Treatment Reviews 82, pages 101934.
Crossref
Crossref
Lawrence A. Stern, Vanessa D. Jonsson & Saul J. Priceman. 2020. Tumor Microenvironment. Tumor Microenvironment
297
326
.
Ramona Rotolo, Valeria Leuci, Chiara Donini, Anna Cykowska, Loretta Gammaitoni, Giovanni Medico, Giorgio Valabrega, Massimo Aglietta & Dario Sangiolo. (2019) CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy. International Journal of Molecular Sciences 20:11, pages 2839.
Crossref
Crossref
Solmaz Shirjang, Nazila Alizadeh, Behzad Mansoori, Ata Mahmoodpoor, Hossein Samadi Kafil, Mohammad Hojjat‐Farsangi & Mehdi Yousefi. (2018) Promising immunotherapy: Highlighting cytokine‐induced killer cells. Journal of Cellular Biochemistry 120:6, pages 8863-8883.
Crossref
Crossref
Marina Martinez & Edmund Kyung Moon. (2019) CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment. Frontiers in Immunology 10.
Crossref
Crossref